global provider of customized laboratory and research services

Biomarker/Assay Development

Mount Sinai Services offers a full suite of biomarker development and assay validation services to ensure our clients develop clinically relevant tests and show drug effectiveness.

Engaging us early in your biomarker discovery and development process to help mitigate risks and achieve higher efficiencies. With significant experience in diagnostic kit development and commercialization, we enable our clients to optimize their assay designs and successfully convert biomarker signatures into robust tests. Our development process is guided by fit for purpose, with flexibility to accommodate a range of assay development complexity. We can do direct assay transfer or full development starting with sample procurement and biomarker discovery through clinical validation.

We provide exceptional access to technical expertise and can focus development efforts in the most clinically meaningful directions. We have extensive experience with tissue, cell and fluid-based biomarker assay development in GCLP and non-GCLP environments. The team works with clients in a truly collaborative fashion, using state-of-the-art tools to support development at every stage.

Our capabilities include: Cell biology, Biochemistry, Immunology, Microbiology, Molecular biology and Genomics.